Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in patients with colorectal cancer

2024-515908-39-00 Protocol 2018-001452-36 Phase I and Phase II (Integrated) - Other Ongoing, recruitment ended

Start 29 Oct 2018 · Status Ongoing, recruitment ended · 1 EU/EEA countries · 2 sites · Protocol 2018-001452-36

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruitment ended
Participants planned 48
Countries 1
Sites 2

Patients with metastatic colorectal cancer

Key facts

Sponsor
Centr Georges Francois Leclerc, Centr Georges Francois Leclerc
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Digestive System Diseases [C06]
Trial duration
29 Oct 2018 → ongoing
Decision date (initial)
2024-08-02
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-515908-39-00
EudraCT number
2018-001452-36
ClinicalTrials.gov
NCT03795311

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Patients with metastatic colorectal cancer

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centr Georges Francois Leclerc

Sponsor organisation
Centr Georges Francois Leclerc
Address
1 Rue Professeur Marion
City
Dijon
Postcode
21000
Country
France

Scientific contact point

Organisation
Centr Georges Francois Leclerc
Contact name
Dr Jean-David FUMET

Public contact point

Organisation
Centr Georges Francois Leclerc
Contact name
Sophie Parnalland

Centr Georges Francois Leclerc

Sponsor organisation
Centr Georges Francois Leclerc
Address
1 Rue Professeur Marion
City
Dijon
Postcode
21000
Country
France

Locations

1 EU/EEA country · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruitment ended 48 2
Rest of world 0

Investigational sites

France

2 sites · Ongoing, recruitment ended
Centr Georges Francois Leclerc
Oncology, 1 Rue Professeur Marion, 21000, Dijon
Centre Hospitalier William Morey
Oncology, 4 Rue Capitaine Drillien, Cs 80120, Chalon Sur Saone Cedex

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2018-10-29 2018-10-29 2023-01-16

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-07-01 France Acceptable
2024-08-02
2024-08-02